scholarly journals A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease – strategies for optimizing treatment outcome

2019 ◽  
Vol 33 (12) ◽  
pp. 2253-2263 ◽  
Author(s):  
L. Eicher ◽  
M. Knop ◽  
N. Aszodi ◽  
S. Senner ◽  
L.E. French ◽  
...  
Keyword(s):  
Systematic Review ◽  
Treatment Outcome ◽  
Treatment Adherence ◽  
Skin Disease ◽  
Inflammatory Skin Disease ◽  
Factors Influencing ◽  
Inflammatory Skin

scholarly journals COVID-19 and Psoriasis: A Concise Systematic Review

2021 ◽  
Vol 2 (4) ◽  
Author(s):  
Michelle Silva Rocha ◽  
Lorenna Lemos de Aquino ◽  
Ágda Tamires da Silva Rodrigues ◽  
Clarice Paiva de Oliveira ◽  
Lívia Mendes Montoya Lazo ◽  
...  
Keyword(s):  
Systematic Review ◽  
Skin Disease ◽  
Health Care Services ◽  
Skin Diseases ◽  
Clinical Course ◽  
Immunosuppressive Agents ◽  
Inflammatory Skin Disease ◽  
Biological Products ◽  
Dermatological Disease ◽  
Inflammatory Skin

Introduction: The effects on human health caused by the severe acute respiratory syndrome of coronavirus 2 (SARS-CoV-2) lead to hyperinflammation processes, which can lead to meta-inflammation. This process can aggravate skin diseases, especially psoriasis. This is a chronic inflammatory skin disease associated with significant morbidity. This problem affects about 2-3% of people worldwide. Objective: to demonstrate, through a concise systematic review, the main considerations about the relationship between COVID-19 and psoriasis, showing the possible mechanisms for the worsening of this dermatological disease. Methods: The research was carried out from June 2021 to July 2021 and developed based on Scopus, PubMed, Science Direct, Scielo, and Google Scholar, following the Systematic Review-PRISMA rules. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. Results: Psoriasis is a common chronic inflammatory skin disease and is autoimmune. Patients with COVID-19 may have features of hyper inflammation and even meta-inflammation. The triggering or exacerbating factor of psoriasis may be medications and, in addition, patients with COVID-19 may have psoriasis exacerbation. Reports indicated that psoriasis patients using biological products were no longer susceptible to COVID-19 and the severe clinical course of the disease. It is envisioned that the use of azithromycin in cases of COVID 19 with pre-existing psoriasis can alleviate psoriatic lesions. Conclusion: The COVID 19 pandemic had a direct impact on dermatological diseases, especially psoriasis. Difficulty in accessing health care services and the stress load caused exacerbations in psoriasis cases. Studies recommend avoiding classic immunosuppressive agents such as methotrexate, cyclosporine, and TNF alpha inhibitors. Reports indicated that psoriasis patients using biological products were no longer susceptible to COVID-19 and the severe clinical course of the disease.

Changes in CD44 isoform expression during inflammatory skin disease

1997 ◽  
Vol 22 (03) ◽  
pp. 128-133
Author(s):  
A.J. HARRIS ◽  
D. DEAN ◽  
S. BURGE ◽  
F. WOJNAROWSKA
Keyword(s):  
Skin Disease ◽  
Inflammatory Skin Disease ◽  
Inflammatory Skin ◽  
Isoform Expression

Chronic Systemic Inflammatory Skin Disease as a Risk Factor for Cardiovascular Disease

2021 ◽  
Vol 46 (5) ◽  
pp. 100799
Author(s):  
David A. Bulger ◽  
Sheharyar Minhas ◽  
Abdul Aziz Asbeutah ◽  
Sharif Kayali ◽  
Hamid A.K. Shirwany ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Risk Factor ◽  
Skin Disease ◽  
Inflammatory Skin Disease ◽  
Inflammatory Skin
Sign in / Sign up

Export Citation Format

Share Document